Zheng, Guanqun
Qin, Yidan
Clark, Wesley C
Dai, Qing
Yi, Chengqi
He, Chuan
Lambowitz, Alan M
Pan, Tao
Article History
Received: 10 March 2015
Accepted: 1 June 2015
First Online: 27 July 2015
Competing interests
: Thermostable group II intron reverse transcriptase (TGIRT) enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas at Austin and East Tennessee State University to InGex, LLC. A.M.L. and the University of Texas are minority equity holders in InGex, LLC, and A.M.L. and other present and former members of the Lambowitz laboratory receive royalty payments from sales of TGIRT enzymes and licensing of intellectual property.